Cyclerion Therapeutics (CYCN) Prepaid Assets (2018 - 2025)
Cyclerion Therapeutics (CYCN) recorded quarterly Prepaid Assets of $384000.0 in Q4 2025, up 3390.91% quarter-over-quarter from $11000.0 in Q3 2025, and up 2300.0% on a YoY basis from $16000.0 in Q4 2024.
Cyclerion Therapeutics (CYCN) Prepaid Assets (2018 - 2025) Analysis & Trends
Cyclerion Therapeutics' Prepaid Assets history runs 8 years deep, the most recent figure standing at $384000.0 for Q4 2025.
- In Q4 2025, Prepaid Assets rose 2300.0% year-over-year to $384000.0; the TTM figure through Dec 2025 stood at $384000.0 (up 2300.0% YoY), while the FY2025 annual figure was $384000.0, up 2300.0% from the prior year.
- Prepaid Assets was $384000.0 for Q4 2025 at Cyclerion Therapeutics, up from $11000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.8 million in Q1 2021 to a low of $11000.0 in Q3 2025.
- Historically, Prepaid Assets has averaged $513850.0 across 5 years, with a median of $470500.0 in 2021.
- Biggest YoY gain for Prepaid Assets was 2300.0% in 2025; the steepest drop was 98.23% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $928000.0 in 2021, then slumped by 42.13% to $537000.0 in 2022, then slipped by 17.69% to $442000.0 in 2023, then sank by 96.38% to $16000.0 in 2024, then jumped by 2300.0% to $384000.0 in 2025.
- The last three Prepaid Assets figures came in at $384000.0 (Q4 2025), $11000.0 (Q3 2025), and $27000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 384,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 27,000.00 |
| Mar 31, 2025 | 256,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Sep 30, 2024 | 621,000.00 |
| Jun 30, 2024 | 116,000.00 |
| Mar 31, 2024 | 308,000.00 |
| Dec 31, 2023 | 442,000.00 |
| Sep 30, 2023 | 30,000.00 |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 503,000.00 |
| Dec 31, 2022 | 537,000.00 |
| Sep 30, 2022 | 536,000.00 |
| Jun 30, 2022 | 482,000.00 |
| Mar 31, 2022 | 1.01 Mn |
| Dec 31, 2021 | 928,000.00 |
| Sep 30, 2021 | 459,000.00 |
| Jun 30, 2021 | 766,000.00 |
| Mar 31, 2021 | 1.80 Mn |